Dadx2 & Hubby & Med Oncologist. Current @csoncol fellow. Interested in Time Tox, Pt Prefs, Value in Cancer Care. Views=own.
Kingston, Ontario, Canada
Joined January 2018
- Tweets343
- Following831
- Followers302
- Likes1.8K
Great to talk to Josh from @HemOncToday about this work!
❓Is #TimeToxicity too negative?
Patients, caregivers and oncologists say “toxicity” could communicate judgement on #cancer care choices.
📹 Time commitment, time impact or time trade-off may be more “approachable.” @SamuelXStevens @csoncol @queensu
🔗 bit.ly/40mtzR4
2
3
699
⁉️ Just out JCO OP: Stakeholder Perspectives on “Time Toxicity”
🕰️ “Time toxicity” has gained traction in oncology, highlighting the hidden burden of patients’ time. But does this language reflect stakeholder experiences of time spent on treatment?
Read: ascopubs.org/doi/10.1200/OP-…
2
67
‘Shared Decision Making is about what makes sense for THIS patient; it is a method of care; it is NOT an extra thing to do. We need to create the conditions for care to occur in our health systems.’ Fantastic insights by Prof Victor Montori at @LHSCCanada
1️⃣ Introducing the TIME-DCE study! ⏱️🧬
How do patients, caregivers & oncologists trade off survival, side effects & time spent in healthcare?
Our new qualitative paper lays the groundwork for this upcoming discrete-choice experiment 👇
🔗 link.springer.com/article/10…
1
47
Strongly recommend this prospective study from Indian colleagues reporting the #TimeToxicity of palliative chemo. Very tricky work I'm sure. Great 2 see TT mapped in non-HIC context + linked to practical/policy solutions. Another @credoworkshop success!
spcare.bmj.com/content/early…
3
254
Wonderful to meet @Timothee_MD at #ESMO25! Your work with @VPrasadMDMPH has been so important for how I think about evidence, bias and critical appraisal in oncology. Keep doing great work!
Fabulous discussion of the PSMAddition trial by @AzadOncology at #ESMO25. A ‘positive’ trial yes, but much nuance needed in applying results 👏👏👏
The award for the most honest discussant goes to ... @dr_yakupergun @DrChoueiri @tompowles1 @montypal @myESMO @MyriamChalabi #ESMO25
Very proud to have co-authored this comment on the FDA’s new draft guidance for industry in @TheLancetOncol with @lateuwen and @oncology_bg. The draft guidance takes important steps forward, but there is room for even more improvement. Read more: thelancet.com/journals/lanon…
The fashion stylings of Booth and the hair styling of Gyawali…. @oncology_bg @OncologyBGLab @csoncol
Great to share our work on #timetoxicity with colleagues at @QueensSCRI and @csoncol, though I think the highlight was seeing my wife join the zoom call!
Learning about doing global oncology the right way with @lateuwen at oncology grand rounds! @csoncol @OncologyBGLab
That’s my roommate! Just some of the things that are possible at the Division of Cancer Care and Epidemiology! @oncology_bg
Congratulations to @lateuwen who got 2 papers published in her 1 month sabbatical with us @OncologyBGLab !
Both are open access-
1. bmjoncology.bmj.com/content/… @BMJOncology
2. academic.oup.com/jnci/advanc… @JNCI_Now
🚨Now open 🚨 Apply for the @csoncol fellowship in Health Services Research at @queensu in beautiful #Kingston ON.
✅Work with great people
✅Learn new skills
✅Do meaningful work
✅Live in a great place
Can confirm, family friendly ✅ BYO supportive partner
🚨 Fellowship Opportunity!
The 2026 CSO Fellowship in Health Services Research is now accepting applications. Apply today: tinyurl.com/49j27su9
Based at Queen's University in Kingston, Canada, this 1-year Fellowship is an opportunity to build health services research skills and work with an international team dedicated to advancing cancer care focused on outcomes that matter to patients. If you are an early career medical or clinical oncologist or trainee, this is a can't-miss opportunity.
Deadline to apply: September 18, 2025 @ 4:00 pm EDT.
More information: tinyurl.com/37cdc5sy
Great to share this first piece from my @csoncol fellowship, written with @oncology_bg. We use some issues with CodeBreaK300 to argue that the promise of precision medicines are only fulfilled when coupled with precision in design, analysis and reporting of trials.
New #OpenAccess commentary by @SamuelXStevens and @oncology_bg | CodeBreaK or code blue? Assessing sotorasib's vital signs in metastatic colorectal cancer acsjournals.onlinelibrary.wi… @OncoAlert #CRCSM
Thanks for the tweet @DKarikios! Sad to miss this year’s @MOGA_ORG ASM but timely to reflect on where the fledgling @csoncol movement has come since that fateful ASM where I first met @oncology_bg! Towards #outcomesthatmatter in the Western Pacific, together
What is the role of Common Sense Oncology in the Western Pacific? sciencedirect.com/science/ar…
@csoncol
#cancercare #cancer #commonsenseoncology
🧵 1/
Pleased to share the first paper from my PhD, out today in Supportive Care in Cancer. This study explored how patients with advanced gastrointestinal cancers and their caregivers perceive the “time toxicity” of palliative systemic treatments: link.springer.com/content/pd…
1
95
Great to be able to represent @MOGA_ORG’s Oncology Drug Working Group in this initiative to improve access to cancer drugs in Aus.
theaustralian.com.au/health/…
1
6
323
@NECancerAus @PCPA_Ltd @RareCancers @inheritedcaus @arrotexpharmaceuticals @GICancer @OmicoAustralia @IconCancerCtre @LeukaemiaAus @AstraZeneca @PCFA @Lungfoundation @IQVIA_global
2
107
Congrats @guptaarjun90 on this much needed foundational qualitative work on time toxicity. Hoping to have the 🇦🇺 perspective out soon!
jamanetwork.com/journals/jam…
1
108